These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
4. Prognosis of Masked and White Coat Uncontrolled Hypertension Detected by Ambulatory Blood Pressure Monitoring in Elderly Treated Hypertensive Patients. Pierdomenico SD; Pierdomenico AM; Coccina F; Porreca E Am J Hypertens; 2017 Nov; 30(11):1106-1111. PubMed ID: 29059303 [TBL] [Abstract][Full Text] [Related]
5. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of elevated white blood cell count in hypertension. Schillaci G; Pirro M; Pucci G; Ronti T; Vaudo G; Mannarino MR; Porcellati C; Mannarino E Am J Hypertens; 2007 Apr; 20(4):364-9. PubMed ID: 17386341 [TBL] [Abstract][Full Text] [Related]
7. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Mancia G; Zanchetti A; Agabiti-Rosei E; Benemio G; De Cesaris R; Fogari R; Pessina A; Porcellati C; Rappelli A; Salvetti A; Trimarco B Circulation; 1997 Mar; 95(6):1464-70. PubMed ID: 9118514 [TBL] [Abstract][Full Text] [Related]
8. A study of the white-coat phenomenon in patients with primary hypertension. Zhu N; Bu M; Chen D; Li T; Qian J; Yu Q; Chen Q; Wan C; Qu H; Zhu M; Zou X Hypertens Res; 2008 Jan; 31(1):37-41. PubMed ID: 18360016 [TBL] [Abstract][Full Text] [Related]
9. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators. Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413 [TBL] [Abstract][Full Text] [Related]
10. Adverse prognostic value of a blunted circadian rhythm of heart rate in essential hypertension. Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Telera MP; Pede S; Gattobigio R; Porcellati C J Hypertens; 1998 Sep; 16(9):1335-43. PubMed ID: 9746121 [TBL] [Abstract][Full Text] [Related]
11. The white coat phenomenon is benign in referred treated patients: a 14-year ambulatory blood pressure mortality study. Ben-Dov IZ; Kark JD; Mekler J; Shaked E; Bursztyn M J Hypertens; 2008 Apr; 26(4):699-705. PubMed ID: 18327079 [TBL] [Abstract][Full Text] [Related]
12. Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Pede S; Porcellati C Hypertension; 1998 Dec; 32(6):983-8. PubMed ID: 9856961 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of white coat hypertension by ambulatory blood pressure monitoring. Owens P; Atkins N; O'Brien E Hypertension; 1999 Aug; 34(2):267-72. PubMed ID: 10454452 [TBL] [Abstract][Full Text] [Related]
14. White coat effect in treated hypertensive patients: sex differences. Myers MG; Reeves RA J Hum Hypertens; 1995 Sep; 9(9):729-33. PubMed ID: 8551486 [TBL] [Abstract][Full Text] [Related]
15. [White-coat hypertension]. Verdecchia P; Porcellati C G Ital Cardiol; 1995 Jul; 25(7):899-909. PubMed ID: 7557039 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of strategy for the detection of white coat hypertension based on ambulatory and home blood pressure monitoring. Stergiou GS; Alamara CV; Skeva II; Mountokalakis TD J Hum Hypertens; 2004 Feb; 18(2):85-9. PubMed ID: 14730322 [TBL] [Abstract][Full Text] [Related]
17. Determinants of the white-coat effect in normotensives and never-treated mild hypertensives. Tsai PS Clin Exp Hypertens; 2003 Oct; 25(7):443-54. PubMed ID: 14596368 [TBL] [Abstract][Full Text] [Related]
18. Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy? Verdecchia P; Angeli F; Gattobigio R; Guerrieri M; Benemio G; Porcellati C J Hum Hypertens; 2004 Dec; 18 Suppl 2():S23-8. PubMed ID: 15592569 [TBL] [Abstract][Full Text] [Related]
19. Antihypertensive treatment based on blood pressure measurement at home or in the physician's office: a randomized controlled trial. Staessen JA; Den Hond E; Celis H; Fagard R; Keary L; Vandenhoven G; O'Brien ET; JAMA; 2004 Feb; 291(8):955-64. PubMed ID: 14982911 [TBL] [Abstract][Full Text] [Related]